Company & Sponsor Intelligence

Mazandaran University of Medical Sciences

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials3

Recruiting0

Completed3

Countries1

Therapeutic footprint

epilepsy

Indexed studies

NCT03940326Levetiracetam Versus Valproate in Idiopathic Generalized Tonic-clonic Seizures
epilepsy · IranPHASE4

NCT05160350Probiotic in Treatment of Adult Patients With Drug-resistant Epilepsy
epilepsy · IranPHASE4

NCT06608784Comparison Study of Electrocardiogram Indexes in Patients With Epilepsy, Patients With First Seizure and Normal Population
epilepsy · IranCOMPLETED

Intelligence layer updated: 2026-10-20 06:14:04.499488+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →